Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, announced …
PlasmaTech Biopharmaceuticals Inc (NASDAQ:PTBI), a biopharmaceutical company focused on advancing cell therapy and gene therapy for rare diseases, announced that Todd Wider, MD …